Company Profiles

driven by the PitchBook Platform

Innovent Biologics

Description

Operator of a bio-pharmaceutical company that develops monoclonal antibody products. The company's pipeline focuses on oncology, autoimmune disorders, cardiovascular diseases, inflammatory diseases and ophthalmology.

2011

Founded

PRIVATE

Status

201-500

Employees

Series D

Latest Deal Type

$260M

Latest Deal Amount

$385M

Total Amount Raised

Description

Operator of a bio-pharmaceutical company that develops monoclonal antibody products. The company's pipeline focuses on oncology, autoimmune disorders, cardiovascular diseases, inflammatory diseases and ophthalmology.

Website:

www.innoventbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Biotechnology

Primary Office

168 Dongping Street Suzhou Industrial Park Suzhou, Jiangsu 215123China +86 (0)512 6956 6088
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Innovent Biologics's full profile, request a free trial.

Innovent Biologics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Innovent Biologics Investors (12)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
China Life Private EquityOtherMinority000 0000000 0000
Eight Roads VenturesVenture CapitalMinority000 0000000 0000
F-Prime Capital PartnersVenture CapitalMinority000 0000000 0000
Frontline BioVenturesVenture CapitalMinority000 0000000 0000
Hillhouse Capital ManagementVenture CapitalMinority000 0000000 0000
China Life Private Equity Other
Eight Roads Ventures Venture Capital
F-Prime Capital Partners Venture Capital
Frontline BioVentures Venture Capital
Hillhouse Capital Management Venture Capital

Innovent Biologics Executive Team (15)

NameTitleBoard
Seat
Contact
Info
Michael Yu Ph.DCo-founder, Chairman, President & Chief Executive Officer
Qinwei Zhou Ph.DChief Operating Officer
Shao XuefengFinancial Controller
Xiaolin LiuSenior Vice President, Research & Development
Junjian LiuVice President, Biologics Discovery
Michael Yu Ph.D Co-founder, Chairman, President & Chief Executive Officer
Qinwei Zhou Ph.D Chief Operating Officer
Shao Xuefeng Financial Controller
Xiaolin Liu Senior Vice President, Research & Development
Junjian Liu Vice President, Biologics Discovery

Innovent Biologics Board Members (13)

NameRepresentingRoleSinceContact
Info
Charles Cooney Ph.DSelfBoard Member000 0000
Daniel AuerbachBoard Member000 0000
Darren Cai Ph.DLegend CapitalManaging Director000 0000
Leon ChenSelfBoard Member000 0000
Michael Yu Ph.DInnovent BiologicsCo-founder, Chairman, President & Chief Executive Officer000 0000
Charles Cooney Ph.D Board Member Self
Daniel Auerbach Board Member
Darren Cai Ph.D Managing Director Legend Capital
Leon Chen Board Member Self
Michael Yu Ph.D Co-founder, Chairman, President & Chief Executive Officer Innovent Biologics
Request full access to PitchBook